Form D · Pharmaceuticals
Omthera Pharmaceuticals, Inc.
New Jersey, NJ · CIK 0001477598
Offering snapshot reported Feb 28, 2013 · SEC filing
- Reported sold
- $17.6M Indefinite offering
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 15, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 28, 2013 | Initial | $17,600,000 | No comparison | 13 | SEC filing |
| Jan 6, 2012 | Amendment | $39,009,465 | $5,099,994vs Mar 15, 2011 | 10 | SEC filing |
| Mar 15, 2011 | Initial | $33,909,471 | No comparison | 7 | SEC filing |
| Nov 27, 2009 | Initial | $2,158,333 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-192546
Source: Form D, filed Feb 28, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Carr | Executive |
| Michael Davidson | Executive |
| George Horner | Director |
| Bernardus Machielse | Executive |
| David Mott | Director |
| Christian Schade | Executive |
| Graziano Seghezzi | Director |
| Gerald Wisler | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
707 State Road
New Jersey, NJ, 08540
New Jersey, NJ, 08540